Source: International Congress 2018 – Pathobiology of pulmonary hypertension
Disease area: Pulmonary vascular diseases



Rating:

Share or cite this content

Citations should be made in the following way:
K. Kurakula (Leiden, Netherlands), X. Sun (Amsterdam, Netherlands), C. Happé (Amsterdam, Netherlands), M. Goumans (Leiden, Netherlands), H. Bogaard (Amsterdam, Netherlands). Pharmacological activation of Nur77 enhances BMP signalling and inhibits vascular remodelling in pulmonary arterial hypertension. 3937

Member's Comments

No comment yet.

Related content which might interest you: NMDA receptor activation promotes vascular remodeling and pulmonary arterial hypertension Source: International Congress 2018 – Pathobiology of pulmonary hypertension Year: 2018 Notch1 signalling regulates endothelial proliferation and apoptosis in pulmonary arterial hypertension Source: Eur Respir J 2016; 48: 1137-1149 Year: 2016 TSC1/mTOR pathway promotes hypoxia-induced pulmonary hypertension in mice Source: Annual Congress 2012 - Pulmonary circulation: basic mechanisms, animal models and experimental treatments Year: 2012 Suppression of HIF2 signalling attenuates the initiation of hypoxia-induced pulmonary hypertension Source: Eur Respir J, 54 (6) 1900378; 10.1183/13993003.00378-2019 Year: 2019 6-aminonicotinamide ameliorates pulmonary fibrosis by suppressing the TGF-beta1 activated Smad signalling pathway Source: Virtual Congress 2020 – Translational therapeutic advances Year: 2020 2-Methoxyestrone inhibits vascular remodeling and attenuates monocrotaline-induced pulmonary hypertension Source: Annual Congress 2008 - Pulmonary vascular biology Year: 2008 Effects of BMPR-II signal transduction in the pulmonary vascular remodeling of monocrotaline induced pulmonary hypertension in rats Source: Annual Congress 2008 - Pathophysiology of pulmonary hypertension Year: 2008 2-Ethoxyestradiol inhibits vascular and cardiac remodeling and attenuates monocrotaline-induced pulmonary hypertension Source: Annual Congress 2007 - Cellular and molecular aspects of pulmonary hypertension Year: 2007 A novel piperidine attenuates pulmonary arterial hypertension via regulating BMP2 and PTGS2 levels Source: International Congress 2018 – Pathobiology of pulmonary hypertension Year: 2018 Activation of AMPK inhibits pulmonary arterial remodeling Source: International Congress 2015 – Pulmonary hypertension: novel insights into the biology of the disease Year: 2015 AntagomiR directed against miR-20a restores BMP signaling in hypoxia-induced pulmonary hypertension in vivo Source: Annual Congress 2011 - Molecular: pathology of infectious and inflammatory lung disease Year: 2011 Decreased expression of the TGF-beta type I receptor ALK1 in pulmonary arterial hypertension Source: Annual Congress 2007 - Cellular and molecular aspects of pulmonary hypertension Year: 2007 TRIM33 prevents pulmonary fibrosis by impairing TGF-ß1 signalling Source: Eur Respir J, 55 (6) 1901346; 10.1183/13993003.01346-2019 Year: 2020 The effect of ASK1 inhibition on hypoxia-induced pulmonary artery fibroblast activation and associated paracrine effects on vascular smooth muscle cells Source: International Congress 2016 – The nature of pulmonary hypertension Year: 2016 Dysregulated bone morphogenetic protein signaling in pulmonary arterial hypertension Source: Annual Congress 2008 - Pathophysiology of pulmonary hypertension Year: 2008 Targeting bone morphogenic protein receptor 2 (BMPR2) signalling to treat pulmonary arterial hypertension Source: Eur Respir J, 50 (3) 1701370; 10.1183/13993003.01370-2017 Year: 2017 ACE2 activation improves pulmonary endothelial function and attenuates monocrotaline-induced pulmonary hypertension Source: Annual Congress 2011 - Treatment of human pulmonary hypertension Year: 2011 Oestrogen inhibition reverses pulmonary arterial hypertension and associated metabolic defects Source: Eur Respir J, 50 (2) 1602337; 10.1183/13993003.02337-2016 Year: 2017 Selective TSC1 deletion in smooth muscle activates mTOR signaling and induces pulmonary hypertension Source: International Congress 2015 – Pulmonary hypertension: promising small molecules Year: 2015